REG - Reckitt Benckiser Gp - 2025 SHARE BUYBACK PROGRAMME – FIRST TRANCHE

Reckitt BenckiserAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250728:nRSb6936Sa&default-theme=true

RNS Number : 6936S  Reckitt Benckiser Group PLC  28 July 2025

28 July 2025

 

RECKITT BENCKISER GROUP PLC

 

2025 SHARE BUYBACK PROGRAMME

 

Reckitt Benckiser Group plc ("Reckitt" or the "Company") announces that in
connection with its intention to commence its latest £1 billion 2025 share
buyback programme (the "Programme") over the next 12 months, which was
announced on 24 July 2025, the 2025 Programme will commence on 28 July 2025.
The purpose of the new share buy-back programme is to increase returns to
shareholders and to reduce the share capital of Reckitt.

 

In accordance with the Company's general authority to make market purchases of
existing ordinary shares of 10 pence each in the share capital of the Company
(the "Ordinary Shares") as granted by shareholders at the Company's Annual
General Meeting on 8 May 2025, the Company will purchase no more than
68,400,000 Ordinary Shares. The first tranche of the Programme will commence
on 28 July 2025 and is expected to end no later than 31 October 2025. The
First Tranche will return up to £250 million of capital to shareholders. All
shares repurchased under the First Tranche will be cancelled.

 

Reckitt announces that it has entered into an agreement with RBC Europe
Limited ("RBC") under which it has issued an instruction to RBC to manage the
first tranche of the Programme.  RBC will, acting as riskless principal,
purchase Ordinary Shares for an aggregate purchase price of no greater than
£250 million and will simultaneously sell such Ordinary Shares on to the
Company.

 

Any purchase of Ordinary Shares in relation to this announcement will be
carried out on the London Stock Exchange and Multilateral Trading Facilities,
as defined by the Directive 2014/65/EU on markets in financial instruments
(including the delegated and implementing acts adopted under it) as
implemented, retained, amended, extended, re-enacted or otherwise given effect
in the United Kingdom from 1 January 2021 and as amended or supplemented in
the United Kingdom thereafter, and executed in accordance with the Listing
Rules and Reckitt's general authority to make market purchases of Ordinary
Shares. The shares will be purchased in accordance with the price and volume
conditions set out in the Commission Delegated Regulation (EU) 2016/1052 of 8
March 2016 supplementing Regulation (EU) No 596/2014 of the European
Parliament and of the Council with regard to regulatory technical standards
for the conditions applicable to buyback programmes and stabilisation measures
as implemented, retained, amended, extended, re-enacted or otherwise given
effect in the United Kingdom from 1 January 2021 and as amended or
supplemented in the United Kingdom thereafter.

 

Reckitt will announce any market repurchase of Ordinary Shares no later than
7.30 a.m. on the business day following the calendar day on which the
repurchase occurred. To the extent permitted by law, Ordinary Shares purchased
under the first tranche of the Programme will be cancelled. For the avoidance
of doubt, no repurchases will be made in respect of the Company's American
Depository Receipts.

 

Any further tranches of the Programme, which may be conducted after completion
of this first tranche, will be announced in due course.

 

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

 

For further Information:

 

Catheryn O'Rourke

Company Secretary

 

Tel +44 (0) 1753 217 800

 

 

Nick Ashworth

Investor Relations Director

 

Tel. +44 (0) 7408 812350

 

 

About Reckitt*:

 

We make the products people trust to care for the ones they love. We are home
to some of the world's best-loved consumer health and hygiene brands,
including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen,
Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By
creating innovative, science-backed solutions, we support people every day to
live healthier lives.

 

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner,
healthier world. This commitment goes beyond the products we make. Through our
actions, we expand access to healthcare, education and economic opportunities.
We support the planet by reducing waste, conserving resources and driving
sustainable innovation.

 

We believe good health starts at home. With every action we take, we strive to
make our consumers' lives easier, cleaner and healthier, to strengthen
communities and to create a more sustainable future.

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFLADRIEFIE